Our top pick for
Resonant Inc is a semiconductors business based in the US. Resonant shares (RESN) are listed on the NASDAQ and all prices are listed in US Dollars. Resonant employs 77 staff and has a trailing 12-month revenue of around USD$3 million.
|52-week range||USD$0.9506 - USD$8.33|
|50-day moving average||USD$6.1721|
|200-day moving average||USD$3.4179|
|Wall St. target price||USD$6.73|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.011|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$3 million|
|Gross profit TTM||USD$735,000|
|Return on assets TTM||-70.31%|
|Return on equity TTM||-165.2%|
|Market capitalisation||USD$284.3 million|
TTM: trailing 12 months
There are currently 4.7 million Resonant shares held short by investors – that's known as Resonant's "short interest". This figure is 7% down from 5.1 million last month.
There are a few different ways that this level of interest in shorting Resonant shares can be evaluated.
Resonant's "short interest ratio" (SIR) is the quantity of Resonant shares currently shorted divided by the average quantity of Resonant shares traded daily (recently around 2.7 million). Resonant's SIR currently stands at 1.71. In other words for every 100,000 Resonant shares traded daily on the market, roughly 1710 shares are currently held short.
However Resonant's short interest can also be evaluated against the total number of Resonant shares, or, against the total number of tradable Resonant shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Resonant's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Resonant shares in existence, roughly 90 shares are currently held short) or 0.0931% of the tradable shares (for every 100,000 tradable Resonant shares, roughly 93 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Resonant.
Find out more about how you can short Resonant stock.
We're not expecting Resonant to pay a dividend over the next 12 months.
Over the last 12 months, Resonant's shares have ranged in value from as little as $0.9506 up to $8.33. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Resonant's is 2.5475. This would suggest that Resonant's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Resonant Inc., a late-stage development company, designs and develops filters for radio frequency (RF) and front-ends used in the mobile device, automotive, medical, Internet-of-things, and related industries in the United States and internationally. It uses Infinite Synthesized Networks technology, a software platform to configure and connect resonators that are building blocks of RF filters. The company develops a series of single-band designs for frequency bands; and multiplexer filter designs for two or more bands to address the carrier aggregation requirements, as well as filter designs to replace various filters and associated componentry for various bands. Resonant Inc. was incorporated in 2012 and is headquartered in Goleta, California.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.